New oral cocktail aims to tame myeloma with fewer side effects
Disease control
Completed
This phase 2 study tested a combination of three oral drugs (ixazomib, cyclophosphamide, and dexamethasone) as the first treatment for multiple myeloma in 12 newly diagnosed patients. The goal was to see if this all-oral regimen could control the disease effectively while causing…
Phase: PHASE2 • Sponsor: John L. Reagan • Aim: Disease control
Last updated May 14, 2026 12:04 UTC